These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 389166)

  • 1. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies during Puva therapy.
    Bjellerup M; Bruze M; Forsgren A; Krook G; Ljunggren B
    Acta Derm Venereol; 1979; 59(1):73-5. PubMed ID: 84474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibodies and PUVA photochemotherapy.
    Kubba R; Steck WD; Clough JD
    Arch Dermatol; 1981 Aug; 117(8):474-7. PubMed ID: 6973321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibodies appearing during PUVA therapy.
    Bruze M; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibodies in mice induced by long wave ultraviolet radiation (UVA).
    Bruze M; Forsgren A; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):25-30. PubMed ID: 2578702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
    Boer J; Hermans J; Schothorst AA; Suurmond D
    Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy.
    Bruze M; Krook G; Ljunggren B
    Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light.
    Abel EA; Goldberg LH; Farber EM
    Arch Dermatol; 1980 Nov; 116(11):1257-61. PubMed ID: 7436431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemotherapy for psoriasis with orally administered methoxsalen.
    Wolff KW; Fitzpatrick TB; Parrish JA; Gschnait F; Gilchrest B; Hönigsmann H; Pathak MA; Tannenbaum L
    Arch Dermatol; 1976 Jul; 112(7):943-50. PubMed ID: 820269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemotherapy of psoriasis using methoxsalen and sunlight. A controlled study.
    Parrish JA; White AD; Kingsbury T; Zahar M; Fitzpatrick TB
    Arch Dermatol; 1977 Nov; 113(11):1529-32. PubMed ID: 337903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General principles of radiation and drug dosage and determination of individual sensitivity of patients to photochemotherapy treatment (PUVA) of psoriasis].
    Jakubowicz K; Langner A; Nowakowski H; Wolska H
    Przegl Dermatol; 1979; 66(4):337-43. PubMed ID: 493560
    [No Abstract]   [Full Text] [Related]  

  • 15. Photochemotherapy of psoriasis (PUVA).
    Rosten M
    N Z Med J; 1979 Aug; 90(641):101-2. PubMed ID: 290909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with photochemotherapy with 8-methoxypsoralene by mouth and long-wave ultraviolet light (PUVA-treatment) in psoriasis].
    Suurmond D; Burger PM; Schothorst AA; Smit AF; van Vloten WA; Polano MK
    Ned Tijdschr Geneeskd; 1978 Jan; 122(3):69-75. PubMed ID: 622199
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
    Stern RS; Momtaz K
    Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
    Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
    N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
    Stern RS; Lange R
    Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibodies during psoralens plus ultraviolet A (PUVA) therapy--are they worthwhile?
    Picascia DD; Rothe M; Goldberg NS; Roenigk HH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):574-7. PubMed ID: 3493272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.